AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 AUG 13 - (NewsRx.com & NewsRx.net) -- Transfection of dendritic cells with RNA induced CD4- and CD8-mediated T cell immunity against breast cancer and revealed the immunodominance of presented T cell epitopes.
"Transfection of dendritic cells (DC) with tumor-derived RNA has recently been shown to elicit tumor-specific CTL capable of recognizing and lysing a variety of tumor cells. In our study we analyzed the induction of HLA class I- and II-restricted T cell responses against MCF-7 breast cancer cells. Using this approach we were able to elicit CD4- and CD8-mediated antitumor responses," researchers in Germany report.
"The CTL specifically lysed MCF-7 cells and DC electroporated with MCF-7 RNA, but spared control cell lines," said Martin R. Muller and colleagues at the University of Tubingen. "The specificity of the cytotoxic activity was confirmed in cold target inhibition assays and using monoclonal antibodies blocking HLA class I molecules. Interestingly, these polyclonal cytotoxic T cells recognized selectively two epitopes derived from the MUC1 and Her-2/neu tumor antigens. The induced Th cells ...